OVA Conjugated Osteoclast Associated Receptor (OSCAR) Homo sapiens (Human) Conjugated small molecules

PIGR3; Osteoclast Associated,Immunoglobulin-Like Receptor; Polymeric immunoglobulin receptor 3; Poly-Ig receptor 3

Add to Cart Distributors
Overview
Properties
  • SourceProtein Conjugation
  • Original Molecular Massn/a
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • OVA Conjugated Osteoclast Associated Receptor (OSCAR) Packages (Simulation)
  • OVA Conjugated Osteoclast Associated Receptor (OSCAR) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Formula

Usage

Reconstitute in PBS or others.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Quantitative proteomics reveals novel functions of osteoclast-associated receptor in STAT signaling and cell adhesion in human endothelial cellsPubMed: 22985931
  • The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic jointsPubMed: 23146195
  • Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitroarticle:10.1007
  • Development of a novel polysaccharide-based iron oxide nanoparticle to prevent iron accumulation-related osteoporosis by scavenging reactive oxygen …Pubmed: 33049237

Recommend products